CLDI icon

Calidi Biotherapeutics
CLDI

Overview Fund Activity

13 hedge funds and large institutions have $3.54M invested in Calidi Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 20 closing their positions.

Holders
13
Holders Change
-12
Holders Change %
-48%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
1
Reduced
2
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MC
1
Meteora Capital
Florida
$1.44M
2
FC
2
Finepoint Capital
Massachusetts
$416K
3
SAMC
3
Spectrum Asset Management (California)
California
$277K
4
RWI
4
Red Wave Investments
Pennsylvania
$188K
5
DCM
5
Driehaus Capital Management
Illinois
$360K

Top Sellers

1
Hudson Bay Capital Management
1
Hudson Bay Capital Management
Connecticut
$0
2
WP
2
Woodline Partners
California
$0
3
KL
3
KIM LLC
Kansas
$0
4
SFM
4
Spartan Fund Management
Canada
$0
5
6CM
5
683 Capital Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MF
26
Magnetar Financial
Illinois
– – -63,132 Closed
BFM
27
Boothbay Fund Management
New York
– – -43,987 Closed
ASM
28
ATW SPAC Management
New York
– – -42,012 Closed
AA
29
AQR Arbitrage
Connecticut
– – -40,464 Closed
KIM
30
Karpus Investment Management
New York
– – -24,200 Closed
CCM
31
CAAS Capital Management
New York
– – -20,600 Closed
RL
32
RPO LLC
Connecticut
– – -13,610 Closed
COPPSERS
33
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– – -13,400 Closed
CFGS
34
Concourse Financial Group Securities
Alabama
– – – –
SCM
35
Shaolin Capital Management
Florida
– – – –
1
2